Impaired Cognition
32
2
2
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.3%
2 terminated out of 32 trials
91.7%
+5.2% vs benchmark
31%
10 trials in Phase 3/4
23%
5 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (32)
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
Simultaneous Recumbent Cycling and Cognitive Training
Cognitive Training in Parkinson Study
Digital Game: A Scale to Evaluate the Perioperative Cognitive Function
Synaptic Plasticity and Cognitive Function in RASopathies
Physical Activity to Patients With Dementia and Their Caregivers.
Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder
A Study on Better Cognitive Functioning Through Braintraining on the Internet
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Exposure to General Anaesthesia in Infancy and Neurocognitive Development
Comparisons of gaIt aNalyses pERformance Between the Gaitrite walkwaYs
Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
Mirabegron in Parkinson Disease and Impaired Cognition
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery
Behavioral Interventions to Prevent or Delay Dementia
Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects
The Impact of Family Financial Support on Cognition
Pre-stroke Cognitive Status and Thrombolytic Therapy